Recruiting
A Study of Experimental Medication BMS-986235 in Healthy Subjects - CV018-001
Updated: 17 April, 2020 | ClinicalTrials.gov
Print Friendly Summary
Trial Details
Phase
Gender(s)
Age Range
Location(s)
Recruiting
Treatment Options
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Patients must be normal healthy volunteers as determined by no clinically significant deviations in medical history, physical examination, ECGs, vital signs, and clinical laboratory determinations - Patients must have a body mass index (BMI) of 18 - 30 mg/kg2, inclusive Exclusion Criteria: - Patients that are pregnant - Patient with any significant acute or chronic medical illness - Patient with a current or recent (within 3 months of study treatment administration) gastrointestinal disease that could affect absorption - Patient with any surgery within 12 weeks of study treatment administration - Patient with any gastrointestinal surgery that could impact upon the absorption of study drug - Patient who donated blood to a blood bank or in a clinical study (except a screening visit) within 12 weeks of study drug administration (within 2 weeks for plasma only) - Patient who received a blood transfusion within 12 weeks of study drug administration Other protocol defined inclusion/exclusion criteria could apply
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
